Here are the recent medical research articles on the subject:
INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF MACULAR EDEMA IN CENTRAL RETINAL VEIN OCCLUSION: A Short-Term Study.
Retina. 26(3):279-284, March 2006.
They conclude that there are no short-term safety concerns with Avastin. They saw improvement in visual acuity and decrease in macular swelling(the place where your vision cells are in the eye)
INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.
Retina. 27(4):419-425, April/May 2007.
They found improvements in their patients treated with avastin, and found a lack of serious side effects.
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONS: IBeVO Study.
Retina. 27(2):141-149, February 2007.
They found injections were well tolerated and associated with stability or improvement in their patients.
All of these studies were done on a small number of patients, so overall conclusions can't be made, but this appears to be a promising treatment for retinal vein occlusion.
__________________
Please click "ACCEPT" if I answered your question to your satisfaction. A BONUS is appreciated. If you have other questions, please ask them.
M.D. - Neurological Surgery
